-
1
المؤلفون: Lilla Reiniger, Dezső Ribli, Dávid Szüts, Zsofia Sztupinszki, Tibor Glasz, Marcin Krzystanek, István Csabai, Eszter Németh, Orsolya Pipek, Zoltan Szallasi, Judit Moldvay
المصدر: International journal of cancer. 145(3)
مصطلحات موضوعية: Cancer Research, Lung Neoplasms, Afatinib, Adenocarcinoma of Lung, medicine.disease_cause, 03 medical and health sciences, T790M, Genomic Imprinting, 0302 clinical medicine, medicine, Humans, Neoplasm Metastasis, Gene, Allele frequency, Protein Kinase Inhibitors, Retrospective Studies, Cisplatin, Gene Rearrangement, Mutation, Models, Genetic, business.industry, Cancer, Gefitinib, medicine.disease, ErbB Receptors, Oncology, Mutagenesis, 030220 oncology & carcinogenesis, Cancer research, Adenocarcinoma, business, Algorithms, medicine.drug, Genome-Wide Association Study
وصف الملف: application/pdf
-
2
المؤلفون: Nicolai Juul Birkbak, April Greene-Colozzi, Andrea L. Richardson, Nadine Tung, Marcin Krzystanek, James Dirk Iglehart, Matija Dreze, Zhenxiong Wang, Yi Li, Daniel P. Silver, P. D. Ryan, Christian Bowman-Colin, Shailja Pathania, Judy Garber, Zsofia Sztupinszki, Miklos Diossy, Dávid Szüts, Zoltan Szallasi
المصدر: Birkbak, N J, Li, Y, Pathania, S, Greene-Colozzi, A, Dreze, M, Bowman-Colin, C, Sztupinszki, Z, Krzystanek, M, Diossy, M, Tung, N, Ryan, P D, Garber, J E, Silver, D P, Iglehart, J D, Wang, Z C, Szuts, D, Szallasi, Z & Richardson, A L 2018, ' Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple negative breast and serous ovarian cancers ', Annals of Oncology, vol. 29, no. 4, pp. 903-909 . https://doi.org/10.1093/annonc/mdy049
Annals of Oncologyمصطلحات موضوعية: 0301 basic medicine, DNA damage, DNA repair, Antineoplastic Agents, Platinum Compounds, Triple Negative Breast Neoplasms, 03 medical and health sciences, chemistry.chemical_compound, platinum based chemotherapy, SDG 3 - Good Health and Well-being, Fanconi anemia, Breast Tumors, medicine, Humans, platinum-based chemotherapy, gene expression-based predictor of treatment sensitivity, Triple-negative breast cancer, Cisplatin, Ovarian Neoplasms, Gene knockdown, RecQ Helicases, gene expression based predictor of treatment sensitivity, business.industry, Hematology, Original Articles, medicine.disease, 030104 developmental biology, ovarian cancer, Oncology, Paclitaxel, chemistry, triple negative breast cancer, Cancer research, triple-negative breast cancer, Female, business, Ovarian cancer, medicine.drug, DNA Damage
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd70a5a6791a61aa289aa2a6476e4d48
https://orbit.dtu.dk/en/publications/2d81ef14-e8b1-46c4-8ddc-387d560a35f0 -
3
المؤلفون: Nnennaya Kanu, Dávid Szüts, Bernadett Szikriszt, Orsolya Pipek, Gábor E. Tusnády, János Molnár, Zoltan Szallasi, Marcin Krzystanek, Zoltán Szeltner, Dezso Ribli, Ádám Póti, Charles Swanton, István Csabai
المصدر: Szikriszt, B, Poti, A, Pipek, O, Krzystanek, M, Kanu, N, Molnar, J, Ribli, D, Szeltner, Z, Tusnady, G E, Csabai, I, Szallasi, Z I, Swanton, C & Szuts, D 2016, ' A comprehensive survey of the mutagenic impact of common cancer cytotoxics ', Genome Biology, vol. 17, 99 . https://doi.org/10.1186/s13059-016-0963-7
Genome Biologyمصطلحات موضوعية: 0301 basic medicine, Mutation rate, DNA repair, DNA damage, Genes, BRCA2, Antineoplastic Agents, Biology, medicine.disease_cause, 03 medical and health sciences, Mutation Rate, SDG 3 - Good Health and Well-being, Cell Line, Tumor, medicine, Animals, Cytotoxics, Spontaneous mutagenesis, Cyclophosphamide, Etoposide, Genetics, Cisplatin, Mutation, Genome, Cytotoxins, Research, Mutagenesis, DT40, Cancer, medicine.disease, BRCA2, 3. Good health, 030104 developmental biology, Whole genome sequencing, Cancer chemotherapy, Drug Screening Assays, Antitumor, Chemotherapy resistance, Chickens, Mutagens, medicine.drug
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940938a119d56c5d213114c3c0833529
https://orbit.dtu.dk/en/publications/1f45e87b-9ed2-41c6-bd83-6552b579848b -
4
المؤلفون: Sander Kelderman, Christian U. Blank, Martin Gore, Andrew Furness, Zoltan Szallasi, Patricia M. M. B. Soetekouw, Marcin Krzystanek, Alexandra Renn, Rob R. H. van den Brom, Ellen Kapiteijn, Ton N. Schumacher, James Larkin, Geke A. P. Hospers, Jan Willem B. de Groot, Rob L. H. Jansen, Bianca Heemskerk, John B. A. G. Haanen, Alfonsus J. M. van den Eertwegh, Edward Fiets, Harm van Tinteren, Paul Lorigan
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical oncology, CCA - Innovative therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: Cancer Immunology Immunotherapy, 63(5), 449-458. SPRINGER
Cancer Immunology, Immunotherapy, 63(5), 449-458
Cancer Immunology, Immunotherapy
Kelderman, S, Heemskerk, B, van Tinteren, H, van den Brom, R R H, Hospers, G A P, van den Eertwegh, A J M, Kapiteijn, E W, de Groot, J W B, Soetekouw, P, Jansen, R L, Fiets, E, Furness, A J S, Renn, A, Krzystanek, M, Szallasi, Z, Lorigan, P, Gore, M E, Schumacher, T N M, Haanen, J B A G, Larkin, J M G & Blank, C U 2014, ' Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma ', Cancer Immunology and Immunotherapy, vol. 63, no. 5, pp. 449-458 . https://doi.org/10.1007/s00262-014-1528-9
Cancer Immunology and Immunotherapy, 63(5), 449-458. Springer Science and Business Media Deutschland GmbH
Cancer Immunology Immunotherapy, 63(5), 449-458. Springerمصطلحات موضوعية: Oncology, Male, Cancer Research, Skin Neoplasms, Kaplan-Meier Estimate, Immunology and Allergy, Melanoma, Aged, 80 and over, education.field_of_study, IMPROVED SURVIVAL, Antibodies, Monoclonal, Lactate dehydrogenase, Middle Aged, CANCER, LYMPHOCYTE, Treatment Outcome, SAFETY, Cohort, Female, Immunotherapy, medicine.drug, Adult, medicine.medical_specialty, Adolescent, GLYCOLYSIS, Immunology, Population, Ipilimumab, Disease-Free Survival, Young Adult, Internal medicine, Blocking antibody, REGRESSION, ANTI-PD-1, medicine, Biomarkers, Tumor, Humans, education, Adverse effect, Aged, L-Lactate Dehydrogenase, business.industry, Biomarker, medicine.disease, Surgery, Clinical trial, ANTIBODY, Cutaneous melanoma, EXPERIENCE, EXPANDED ACCESS PROGRAM, business
-
5
المؤلفون: Marco Gerlinger, Martin Gore, Claudio R. Santos, Lisa Pickering, James Larkin, Charles Swanton, Muhammad A. Khattak, Farrah Bakr, Zoltan Szallasi, Marcin Krzystanek
المصدر: Khattak, M A, Bakr, F, Krzystanek, M, Szallasi, Z I, Gerlinger, M, Santos, C, Swanton, C, Pickering, L M, Gore, M E & Larkin, J M G 2013, ' Prognostic and Predictive Markers in Metastatic Renal Cell Carcinoma ', Journal of Clinical Oncology, vol. 31, no. 7, pp. 20971-972 . https://doi.org/10.1200/JCO.2012.46.9353
مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, medicine.drug_class, Antineoplastic Agents, Pharmacology, Tyrosine-kinase inhibitor, Biomarkers, Pharmacological, Renal cell carcinoma, Internal medicine, medicine, Humans, Progression-free survival, Carcinoma, Renal Cell, Sirolimus, Everolimus, L-Lactate Dehydrogenase, business.industry, Sunitinib, TOR Serine-Threonine Kinases, Hazard ratio, medicine.disease, Temsirolimus, Kidney Neoplasms, Axitinib, Female, business, medicine.drug, Transcription Factors
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::111560031840fbb9d6ac6e66ee5c6b32
https://pubmed.ncbi.nlm.nih.gov/23565533 -
6
المؤلفون: Christian U. Blank, Alex Renn, Rob R. H. van den Brom, Zoltan Szallasi, Marcin Krzystanek, W. Edward Fiets, Rob L. H. Jansen, Sander Kelderman, Ton N. Schumacher, Geke A. P. Hospers, Harm van Tinteren, James Larkin, John B. A. G. Haanen, Andrew James Scott Furness, Alfons J.M. van den Eertwegh, Ellen Kapiteijn, Jan Willem de Groot, Bianca Heemskerk, Paul Lorigan, Martin Gore
المصدر: Journal of Clinical Oncology
ResearcherIDمصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Phase iii trials, Metastatic melanoma, business.industry, Ipilimumab, Internal medicine, Immunology, Blocking antibody, medicine, Selection criterion, business, medicine.drug, Serum lactate dehydrogenase
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86394ab962326a555b5406a2603e5c29
https://doi.org/10.1200/jco.2013.31.15_suppl.3036
إعادة تعيين المنقحات
عرض المنقحات (%%عد%%)
Find this article in full text from Springer Verlag.